🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

E se la colpa della bassa produttività e conseguenti modelli di business antiquati, basso ebitda e bassi salari fosse del livello inadeguato del capitale umano?

Great team for even greater achievements!! Thank you to my mentors Riccardo Autorino MD PhD FACS and Alessandro Antonelli MD FRCS(Glasg)

Trimodal therapy vs radical cystectomy in patients with muscle-invasive #BladderCancer: a systematic review and meta-analysis Francesco Ditonno @AleVeccia88 Celeste Manfredi Alexander Kutikov MD Riccardo Autorino MD PhD FACS Alessandro Antonelli MD FRCS(Glasg) doi.org/10.1111/bju.16…

Stay updated on BPH surgery outcomes!ℹ️ We've analyzed #UrethralStricture incidence & management across different techniques. Discover the results in our latest Prostate Cancer and Prostatic Diseases publication!👨‍🔬💡 🚱 <5% urethral strictures post-surgery 🛠 >90% treated with minimally invasive methods

Our comparative analysis focused on the perioperative and functional outcomes of single-layer vs. double-layer #renorrhaphy #technique during #robotic partial nephrectomy is online! ➡️ pubmed.ncbi.nlm.nih.gov/38742552/ Visual abstract ⬇️

Another great effort by the ROBUUST collaborative group 2.0 to shed light on the role of diagnostic ureteroscopy in high-risk UTUC patients! Our results suggest that URS is a key part of the diagnostic work-up of UTUC patients pubmed.ncbi.nlm.nih.gov/38760274/

A population-based analysis of the socioeconomic impact of minimally invasive surgery for kidney cancer in clinical practice: ✔️ Increase adoption of MIS ✔️ PN has reduced costs and probability of complications ✔️ SDOH are related to higher complications authors.elsevier.com/a/1j5sMKZx3fyVW

Our single-center experience with LAA for kidney surgery now published on BJU International - LAA can be rapidly implemented (˜5 cases) - Easy access to renal hilum allows to modulate clamping strategy - Extraperitoneal route fosters quicker recovery doi.org/10.1111/bju.16…

Today we had the pleasure to host the residents in #urology from the University of Bologna, for the #Young Urology Contest. A special Saturday morning they spent together with our residents of the University of Verona talking about #BPH and #ProstateCancer. What a nice chance

Kudos to @AleVeccia88 for leading the team and publishing this SR & MA on Urologic Oncology. Radical #cystectomy with #stentless urinary diversion was systematically reviewed to evaluate surgical #outcomes, postoperative complications, and sequelae. Our analysis found no

New study from Università di Verona #Urology team on the Journal of Endourology #LearningCurve evaluation after #HoLEP, with report of the incidences of irritative #symptoms and stress #incontinence at 12 months Link⬇️ authorcite.com/view.aspx?doi=… Visual Abstract⬇️

Kudos to Riccardo Autorino MD PhD FACS & team for leading ROBUUST collaborative NEW BJU International paper on Robotic Nephroureterectomy oncologic outcomes 📈1,118 patients evaluated 📏3-year RFS 59%, MFS 76% ⛑️Grade, stage, and bladder cuff mgmt➡️onc outcomes bjui-journals.onlinelibrary.wiley.com/doi/10.1111/bj…

Out on Minerva Urology and Nephrology, prospective study from the Università di Verona Prof. Antonelli’s team (the COMPAR-P trial): Outcomes of #DaVinci vs #HugoRAS 🤖 #Prostatectomy 🩺 Comparable postoperative complications 🔬 Similar pathology data 📉 No difference in health-related #QoL

🚀 Very proud to announce our latest publication in JAMA Oncology (IF: 28.4) #ProstateCancer in #transgender women: low prevalence (0.62%) and possible bivalent role of hormone therapy (protective factor for onset, risk factor for BCR and BM) emerge from our findings! #LGBTQ+ 🏳️‍⚧️

Uro-team Verona 🫵

Systematic #review and #metaanalysis of studies comparing Intuitive #DaVinci and Medtronic #HugoRAS #robotic platforms for robot-assisted radical #prostatectomy. Out on Prostate Cancer and Prostatic Diseases! Congrats to Francesco Ditonno and the Università di Verona #team for leading the project! Link to

PARP inhibitors in metastatic #ProstateCancer: a comprehensive systematic review and meta-analysis of existing evidence. #AuthorCommentary - PARP inhibitors have transformed #mCRPC care, particularly for BRCA-mutated cases. A systematic review and meta-analysis highlights

Cumulative smoking exposure impacts oncologic outcomes of upper tract urothelial carcinoma buff.ly/4b1ELqG

📢 New study in Prostate Cancer and Prostatic Diseases 🥇First-ever head-to-head comparison: Rezūm vs. ThuLEP for BPH ≥80 mL 📈 ThuLEP: better Qmax and IPSS, but MCID for IPSS not reached 💦 Rezūm: better ejaculation rate, but more postoperative transient dysuria 🔗tinyurl.com/2ea6s7xw

Published by Università di Verona #Urology team in BJUI Compass a comparative #analysis of CT scans and 3D virtual models for preoperative #renal #tumor assessments, demonstrating that 3D models significantly increased interobserver agreement, highlighting their potential to improve